A USF Health preclinical study suggests that kappa-opioid antagonists offer a potential treatment to help alcohol-dependent patients cut back or quit drinking.
For the full article click here
Targeting dysregulated kappa-opioid receptors reduces working memory deficits in alcohol use disorder